Natixis Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Natixis Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,505	Closed	-$4.5M	–	1376
2021 Q2	$4.5M	Buy	24,505 +675	+3%	+$116K	0.02%	672
2021 Q1	$3.64M	Sell	23,830 -22,112	-48%	-$3.42M	0.02%	696
2020 Q4	$7.18M	Sell	45,942 -22,857	-33%	-$2.94M	0.04%	442
2020 Q3	$7.87M	Buy	68,799 +3,806	+6%	+$411K	0.05%	385
2020 Q2	$7.29M	Buy	64,993 +24,562	+61%	+$2.61M	0.05%	396
2020 Q1	$3.63M	Buy	40,431 +8,894	+28%	+$873K	0.03%	561
2019 Q4	$3.41M	Buy	31,537 +10,262	+48%	+$1.1M	0.02%	671
2019 Q3	$2.08M	Sell	21,275 -5,521	-21%	-$622K	0.02%	765
2019 Q2	$3.51M	Buy	26,796 +2,522	+10%	+$325K	0.03%	581
2019 Q1	$3.28M	Buy	24,274 +3,623	+18%	+$451K	0.03%	585
2018 Q4	$2.01M	Sell	20,651 -3,539	-15%	-$418K	0.02%	710
2018 Q3	$3.36M	Buy	24,190 +41	+0.2%	+$5.14K	0.03%	609
2018 Q2	$3M	Buy	24,149 +578	+2%	+$67.6K	0.03%	629
2018 Q1	$2.63M	Buy	23,571 +4,618	+24%	+$552K	0.03%	678
2017 Q4	$2.27M	Sell	18,953 -308	-2%	-$37.5K	0.02%	681
2017 Q3	$2.7M	Buy	19,261 +2,308	+14%	+$314K	0.03%	636
2017 Q2	$2.06M	Buy	16,953 +3,335	+24%	+$388K	0.02%	690
2017 Q1	$1.65M	Buy	13,618 +808	+6%	+$104K	0.02%	747
2016 Q4	$1.57M	Buy	12,810 +2,760	+27%	+$338K	0.02%	730
2016 Q3	$1.23M	Sell	10,050 -2,145	-18%	-$276K	0.02%	759
2016 Q2	$1.42M	Buy	12,195 +1,194	+11%	+$169K	0.02%	712
2016 Q1	$1.53M	Sell	11,001 -1,713	-13%	-$252K	0.02%	688
2015 Q4	$2.42M	Buy	12,714 +1,827	+17%	+$319K	0.04%	547
2015 Q3	$1.7M	Sell	10,887 -50	-0.5%	-$9.12K	0.03%	639
2015 Q2	$1.98M	Sell	10,937 -16,970	-61%	-$2.93M	0.03%	638
2015 Q1	$4.84M	Buy	27,907 +2,520	+10%	+$456K	0.08%	359
2014 Q4	$4.7M	Buy	25,387 +2,392	+10%	+$443K	0.09%	352
2014 Q3	$3.81M	Buy	22,995 +2,108	+10%	+$346K	0.08%	395
2014 Q2	$3.26M	Buy	20,887 +6,382	+44%	+$1.01M	0.05%	561
2014 Q1	$2.21M	Buy	14,505 +9,309	+179%	+$1.48M	0.03%	606
2013 Q4	$690K	Buy	5,196 +3,274	+170%	+$393K	0.01%	824
2013 Q3	$223K	Buy	+1,922	New	+$211K	﹤0.01%	1051

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return